Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals appoints Roby Zomer as CEO

Roby Zomer is one of the founders of MGC Pharmaceuticals.
MGC Pharmaceuticals appoints Roby Zomer as CEO
MGC is focused on medical cannabis

MGC Pharmaceuticals (ASX:MXC) founders were key figures in the Israeli medical cannabis industry.

Roby Zomer is one of these founders, and he has now been promoted to chief executive officer.

Zomer has a proven track record of international success within the biotech and agritech sectors.

Key tasks for Zomer will include being responsible for global operations.

The company recently signed a binding Memorandum of Understanding with the Royal Melbourne Institute of Technology.

The agreement is to collaborate on a research initiative to determine and develop the ideal strains of medicinal cannabis in Australia for the treatment of many diseases and conditions.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

May 08 2019
TGOD has been busy building out its facilities in Ontario, Quebec, and Jamaica and expects to reach combined production of 219,000 kilograms of cannabis around 2021
cannabis extraction
April 09 2019
NextLeaf Solutions is developing intellectual property around converting the cannabis plant into infused products through a scalable, repeatable process
November 14 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use